Related Experiment Video

Updated: Jun 22, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Role of complement in the pathomechanism of atherosclerotic vascular diseases

Gábor Széplaki1, Lilian Varga, George Füst

  • 13rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

Molecular Immunology
|June 9, 2009
PubMed

Insights

The complement system plays a key role in ischemic stroke and related conditions. Inhibiting complement activation may offer a new therapeutic strategy for stroke patients.

Area of Science:

  • Immunology
  • Neurology
  • Cardiovascular Science

Background:

  • The complement system is a crucial part of innate immunity.
  • Its dysregulation is implicated in various inflammatory and cardiovascular diseases.
  • Understanding complement's role in cerebrovascular diseases is vital for developing new treatments.

Purpose of the Study:

  • To review the role of complement activation in atherogenesis and ischemia-reperfusion (I/R) injury.
  • To highlight complement-dependent mechanisms in cerebrovascular diseases, including ischemic stroke and restenosis.
  • To explore the correlation between complement activation and ischemic stroke outcomes.

Main Methods:

  • Comprehensive literature review of complement's role in cardiovascular and cerebrovascular pathologies.
  • Analysis of existing data and recent findings on complement activation in ischemic stroke.
  • Correlation analysis between complement activation levels and disease severity/outcome.

Main Results:

  • Complement activation is significantly involved in atherogenesis and I/R injury.
  • Complement-dependent pathways contribute to the pathogenesis of cerebrovascular diseases like ischemic stroke and restenosis.
  • Strong positive correlation observed between complement system activation and poor outcomes in ischemic stroke patients.

Conclusions:

  • The complement system is a key player in the pathophysiology of ischemic stroke.
  • The degree of complement activation correlates with stroke severity and prognosis.
  • Targeting complement activation presents a promising therapeutic avenue for managing ischemic stroke.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Inflammation01:38

Inflammation

Overview